Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
AI-powered cardiometabolic wellness platform for India’s workforce
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
The trademark rights for these brands will be transferred to Lupin by March next year.
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
Subscribe To Our Newsletter & Stay Updated
